Araceli Biosciences Introduces Endeavor® Live Cell for High-Throughput Kinetic Imaging in Drug Discovery

Araceli Biosciences Launches Endeavor® Live Cell

In a significant step forward in the field of drug discovery, Araceli Biosciences has announced the launch of its new imaging platform, Endeavor® Live Cell. This innovation caters specifically to the dynamic biology involved in large-scale screening processes, providing scientists with high-quality cellular image data necessary for the increasingly popular 'Lab-in-the-Loop' workflows in AI-driven drug research.

Transforming Kinetic Imaging

The Endeavor® Live Cell system brings a revolutionary approach to kinetic imaging, enabling rapid image capture across a full 1536-well plate layout. This feature is particularly crucial for researchers looking to obtain reliable cellular data swiftly, allowing for the observation of biological processes in real-time. According to Matt Beaudet, President and CEO of Araceli Biosciences, the introduction of this technology marks an essential extension of their imaging platform, aiming to facilitate the generation of accurate biological data crucial for modern drug discovery.

High-Throughput Integration

Endeavor® Live Cell's capabilities are designed to support applications where cell behavior can change rapidly. This includes drug response monitoring, assessing cell health and viability, conducting phenotypic screening, tracking organoid and spheroid growth, among other kinetic assays that benefit from high-frequency data collection. The system captures images roughly every four minutes over the entire surface of 1536-well plates, achieving consistent timing and accuracy essential for closing the feedback loop between experimental setups and analytical decisions.

A Collaborative Innovation

The development of the Endeavor® Live Cell platform was a collaborative effort with Okolab, whose expertise in live cell incubation and environmental control has been seamlessly integrated with Araceli's high-throughput imaging technologies. Lara Petrak, Director of Sales at Okolab USA, emphasized the partnership, stating that this collaboration provides researchers with a powerful new tool for exploring dynamic biological processes at an unprecedented scale and speed.

Pioneering AI-Driven Research

With the launch of Endeavor® Live Cell, Araceli further solidifies its role as a pivotal provider of imaging infrastructure in the realm of AI-integrated drug discovery. The platform aligns perfectly with current research demands, offering solutions that support scientists in generating the cellular data vital for 'Lab-in-the-Loop' experiments.

Researchers looking to incorporate high-throughput kinetic imaging into their workflows can access more information on Endeavor® Live Cell by visiting www.aracelibio.com. Araceli Biosciences continues to empower scientific inquiry by providing advanced platforms for scalable and reproducible biological data essential in drug development and extensive screening applications.

About Araceli Biosciences

Araceli Biosciences is devoted to developing cutting-edge platforms for cell imaging aimed at assisting researchers in generating replicable and scalable biological data that is critical in drug discovery and advanced screening applications.

About Okolab

Okolab specializes in designing and manufacturing environmental control solutions for microscopy and other demanding applications, ensuring researchers can maintain stable and precise conditions while conducting experiments with living cells.